A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

Name: A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study
Published: 2020
License: Public Domain

Oncolytics Biotech · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

breast breast-cancer paclitaxel

breast cancer metastatic, breast, breast cancer, locally advanced breast cancer, pelareorep, avelumab, paclitaxel, reovirus, oncolytic virus, hr+ breast cancer, her2- breast cancer, breast malignancy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 856965
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.